MCRB SERES THERAPEUTICS INC Capital Structure Changes 8-K Filing 2025 - Stockholder Approvals On April 10, 2025, Seres Therapeutics' stockholders approved the 2025 Incentive Award Plan allowing for the issuance of 44,604,870 shares and a reverse stock split at a ratio of 1-for-20, effective April 21, 2025.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC